Full View

Clinical trial in a dish: using patient-derived induced pluripotent stem cells to identify risks of drug-induced cardiotoxicity

CK Lam, JC Wu - Arteriosclerosis, Thrombosis, and Vascular …, 2021 - Am Heart Assoc
Drug-induced cardiotoxicity is a significant clinical issue, with many drugs in the market
being labeled with warnings on cardiovascular adverse effects. Treatments are often …
被引用次数：25 相关文章
[PDF] researchgate.net

[PDF][PDF] Clinical Trial in a Dish

Arterioscler Thromb Vasc Biol, 2021 - researchgate.net
Drug-induced cardiotoxicity is a significant clinical issue, with many drugs in the market
being labeled with warnings on cardiovascular adverse effects. Treatments are often …

Clinical Trial in a Dish: Using Patient-Derived Induced Pluripotent Stem Cells to Identify Risks of Drug-Induced Cardiotoxicity.

CK Lam, JC Wu - Arteriosclerosis, Thrombosis, and Vascular …, 2021 - europepmc.org
Drug-induced cardiotoxicity is a significant clinical issue, with many drugs in the market
being labeled with warnings on cardiovascular adverse effects. Treatments are often …

Clinical Trial in a Dish

CK Lam, JC Wu - Arteriosclerosis, Thrombosis, and Vascular Biology, 2021 - cir.nii.ac.jp
抄録< jats: p> Drug-induced cardiotoxicity is a significant clinical issue, with many drugs in
the market being labeled with warnings on cardiovascular adverse effects. Treatments are …

Clinical Trial in a Dish: Using Patient-Derived Induced Pluripotent Stem Cells to Identify Risks of Drug-Induced Cardiotoxicity

CK Lam, JC Wu - Arteriosclerosis, thrombosis, and …, 2021 - pubmed.ncbi.nlm.nih.gov
Drug-induced cardiotoxicity is a significant clinical issue, with many drugs in the market
being labeled with warnings on cardiovascular adverse effects. Treatments are often …